Publication Network
Published journal articles indexed by SCI, SSCI, and AHCI
Long-term outcomes and predictors of recurrence in node-negative early stage breast cancer patients
Journal of Cancer Research and Clinical Oncology
, vol.149, no.16, pp.14833-14841, 2023 (SCI-Expanded)
Evaluation of BRCA1/2 gene mutations in patients with high-risk breast and/or ovarian cancer in Turkey
Akdeniz Odemis D., Celik B., Kilic Erciyas S., Sukruoglu Erdogan O., Tuncer S. B., Kurt Gultaslar B., et al.
TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI
, vol.47, no.5, pp.588-594, 2022 (SCI-Expanded)
Are false-negative rates of sentinel lymph node biopsy after neoadjuvant chemotherapy really associated with poor prognosis in clinically node-positive disease at diagnosis?
ANNALS OF SURGICAL ONCOLOGY
, vol.29, no.SUPPL 1, pp.310-311, 2022 (SCI-Expanded)
Predictive Role of Midtreatment Changes in Survivin, GSTP1, and Topoisomerase 2 alpha Expressions for Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
, vol.36, no.3, pp.215-223, 2013 (SCI-Expanded)
Mammaglobin and maspin transcripts in blood may reflect disease progression and the effect of therapy in breast cancer
GENETICS MOLECULAR RESEARCH
, vol.9, no.1, pp.97-106, 2010 (SCI-Expanded)
Anti-Yo-associated cerebellar syndrome presenting with a brain mass
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY
, no.2, pp.183-184, 2009 (SCI-Expanded)
Malignant Ovarian Germ Cell Tumors A Single-Institution Experience
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
, vol.32, no.2, pp.191-196, 2009 (SCI-Expanded)
Effect of chemotherapy on the integrity of serum DNA in patients with breast cancer.
Annals of Newyork Academy of Science
, vol.1137, pp.175-179, 2008 (SCI-Expanded)
International Trends and Challenges in Breast Cancer as Perceived by Leaders in Medicine, Public Policy, and Advocacy
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
, vol.31, no.5, pp.510, 2008 (SCI-Expanded)
Size distribution of circulating cell-free DNA in sera of breast cancer patients in course of adjuvant chemotherapy
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
, vol.46, pp.311-317, 2008 (SCI-Expanded)
Effect of adjuvant chemotherapy on integrity of free serum DNA in patients with breast cancer
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
, vol.1137, pp.175-9, 2008 (SCI-Expanded)
BRCA1 and BRCA2 mutations in Turkish familial and non-familial ovarian cancer patients: a high incidence of mutations in non-familial cases
HUMAN MUTATION
, vol.20, no.1, pp.28-34, 2002 (SCI-Expanded)
The role of chemotherapy in malignant mixed mullerian tumors of the female genital tract.
ANNALS OF ONCOLOGY
, vol.11, pp.87-88, 2000 (SCI-Expanded)
Long term results and prognostic factors of granulosa cell tumors of the ovary.
ANNALS OF ONCOLOGY
, vol.11, pp.87, 2000 (SCI-Expanded)
Investigation of the molecular changes during chemotherapy in non-Hodgkin's lymphoma
RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY
, vol.100, no.3, pp.301-311, 1998 (SCI-Expanded)
Articles Published in Other Journals
Analysis of circulating microRNAs during adjuvant chemotherapy in patients with luminal A breast cancer.
Mol Clin Oncol.
, vol.3, no.4, pp.954-958, 2015 (Peer-Reviewed Journal)
Endometrium Kanserinde Kemoterapi
Türkiye Klinikleri Jinekoloji Obstetrik
, vol.7, no.3, pp.100-106, 2014 (Peer-Reviewed Journal)
The Frequencies of Breast Cancer BC in Extreme Ages Changing Over Time
Mediterranean Oncology Journal
, vol.1, pp.46-19, 2012 (Peer-Reviewed Journal)
CYP1A1, GSTM1 and NQO1 gene polymorphisms: Genetic risk factors for small cell lung cancer
TURKISH JOURNAL OF CANCER
, vol.35, pp.171-176, 2005 (Peer-Reviewed Journal)
Refereed Congress / Symposium Publications in Proceedings
Comparison of bevacizumab plus doublet chemotherapy regimens in patients with metastatic or recurrent ovarian cancer.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 2 - 06 June 2023
The Investigation of Expression Levels of miR 16-5p, miR-17-5p, miR-638 in Patients With Ovarian Cancer
2. International cancer and ion channel congress, İzmir, Turkey, 22 - 24 September 2019, pp.43
FREQUENCY OF BRCA1 AND BRCA2 MUTATIONS IN PATIENTS WITH UNSELECTED TRIPLE-NEGATIVE BREAST CANCER
VI. International Congress of Molecular Medicine, İstanbul, Turkey, 22 May - 25 September 2017, pp.282
Serviks kanserinde nadir rastlanan metastaz bölgesi: İskiyorektal fossa
22. Ulusal Kanser Kongresi, Turkey, 19 - 23 April 2017
Over Kanserinde HMGB1 ve IRE1'in Önemi
22. Ulusal Kanser Kongresi, Antalya, Turkey, 19 - 23 April 2017, pp.159
Frequency of Large Deletions and Duplications in the BRCA1/2 Genes in Turkish High Risk Breast and Ovarian Cancer Cases
International Breastanbul Conference, İstanbul, Turkey, 10 - 12 November 2016, pp.7
Frequency of ER,PR,HER2 and Triple Negative Hormone Receptors in BRCA1/BRCA2 Gene Mutation Positive Breast Cancer Cases
International Breastanbul Conference, İstanbul, Turkey, 10 - 12 November 2016, pp.60
BRCA1 AND BRCA2 GENE MUTATION FREQUENCY OF HIGH RISK OVARIAN CANCER CASES IN TURKISH POPULATION INCLUDING BALKAN TURKS
ESGO 2016: Prevention in gynaecological malignancies, Antalya, Turkey, 8 - 10 September 2016, pp.2
REGIONAL DISTRIBUTIONS of BRCA1 AND BRCA2 GENE MUTATIONS IN TURKISH HEREDITARY OVARIAN CANCER PATIENTS INCLUDING BALKAN TURKS
ESGO 2016: Prevention in gynaecological malignancies, Antalya, Turkey, 8 - 10 September 2016, pp.1
YÜKSEK RİSKLİ TÜRK MEME KANSERLİ HASTALARDA BRCA1 VE BRCA2 GENLERİNDE GÖRÜLEN SNP/VUS’LARIN DAĞILIMI
6.Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 23 - 27 March 2016, no.246, pp.509
ERKEN YAŞ MEME KANSER HASTALARINDA ÇOKLU GEN ANALİZİ
6.Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 23 - 27 March 2016, no.31, pp.238
Serum Makrofaj Migrasyon İnhibitör Faktörü (MIF) Düzeylerinin Epitelyal Over Kanserli Hastalarda Tanısal, Prediktif ve Prognostik Rolü
5. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 19 - 23 March 2014, pp.420
Epitelyal Over Kanserinin Belirlenmesi Üzerinde Protease Activated Receptor-1(PAR-1) Düzeylerinin Herhangi Bir Tanısal Değeri Var Mıdır?
5. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 19 - 23 March 2014, pp.421
KALITSAL MEME KANSER HASTALARINDA SAPTANAN BRCA1/2 GEN MUTASYONLARININ BÖLGESEL VE ETNİK DAĞILIMI İLE KLİNİK ÖZELLİKLERİ
5. türk tıbbi onkoloji kongresi, Antalya, Turkey, 19 - 23 March 2014
Serum Transforme Edici Büyüme Faktörü-Beta1 (TGF-B1) Seviyelerinin Epitelyal Over Kanserli Hastalarda Klinik Önemi
5. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 19 - 23 March 2014, pp.421
Serum Hücresel Adhezyon Molekülleri (VCAM-1, EPCAM) Seviyelerinin Meme Kanserli Hastalarda Tanısal, Prediktif ve Prognostik Rolü
5. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 19 - 23 March 2014, pp.493
Epitelyal Over Kanserli Hastalarda Yüksek Serum Epidermal Büyüme Faktör Reseptörü (EGFR) Düzeyleri Kötü Progresyonsuz Sağkalımla İlişkilidir
5. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 19 - 23 March 2014, pp.428
2008-2012 Yılları Arasında Kanser Genetiği Polikliniğine Başvuran Yüksek Riskli Meme/Over Kanser Sendromlu Vakalarının Dağılımı
20. ULUSAL KANSER KONGRESİ, Antalya, Turkey, 19 - 23 April 2013
The predictive role of midtreatment changes in survivin, GSTP1 and Topoisomerase 2 alpha expressions for pathologic complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
2011 ASCO Annual Meeting, United States Of America, 1 - 04 June 2011, pp.10539
Phase II study of lapatinib in combination with vinorelbine in patients with ErbB2-amplified recurrent or metastatic breast cancer
JOURNAL OF CLINICAL ONCOLOGY, Alexandrıa, United States Of America, 20 May 2011, vol.29, no.15
Nine versus52 weeks of adjuvant trastuzumab in early breast cancer:An observational study of the Turkısh Oncology Group
JOURNAL OF CLINICAL ONCOLOGY, Alexandrıa, United States Of America, 20 May 2011, vol.29, no.15, pp.629
The ımpact of 21 gene recurrence score (RS)scores on treatment decisions:Retrospective evaluation in Turkish early-stage breast cancer(BC)patients
JOURNAL OF CLINICAL ONCOLOGY, Alexandrıa, United States Of America, 20 May 2011, vol.29, no.5
The changing pattern of risk factors and disease characteristics of breast cancer in Turkey:Across-sectional study of a Turkısh oncology group(BREASTTURK)
JOURNAL OF CLINICAL ONCOLOGY, Alexandrıa, United States Of America, 20 May 2011, vol.29, no.15
Phase II study of loading-dose ibandronate treatment in patients in breast cancer and bone metastases suffering from moderate to severe pain
JOURNAL OF CLINICAL ONCOLOGY, Alexandrıa, United States Of America, 20 May 2010, vol.28, no.15
Association between glutathione s-transferase P1 polymorphisms and time to tumor progression in small cell lung cancer patients
JOURNAL OF CLINICAL ONCOLOGY, Alexandrıa, United States Of America, 20 May 2010, vol.28, no.15
The future of breast cancer research and practice in Asia, Latin America, and the Middle East/North Africa: a qualitative horizon scanning analysis.
31st Annual San Antonio Breast Cancer Symposium, Phıladelphıa, United States Of America, 15 January 2009, vol.69, no.2, pp.328-329
Size distribution o circulating cell-free DNA in sera of breast cancer aptients in course of adjuvant therapy
Symposium on Circulating Nucleic Acids in Plasma Serum-V, Russia, 1 - 04 August 2007, pp.9
Size Distrubution Circulating Cell-Free DNA In Sera of Breast Cancer Patients In Course of Adjuvant Therapy
Symposium on Circulating Nucleic Acids in Plasma/Serum -V, Russia, 1 - 04 August 2007, pp.9
Serum Her2 extracellular domain (ECD) levels, pAkt and pMAPK expressions as potential markers for response to trastuzumab(T)-based therapy in metastatic breast cancer (MBC) patients (PTS). A Turkish oncology group study
31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Turkey, 29 September - 03 October 2006, vol.17, pp.90-91
Factors related with recurrence after complete pathologic response to post- operative chemotherapy in patients with epithelial ovarian cancer
31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Turkey, 29 September - 03 October 2006, vol.17, pp.174
Induction chemotherapy followed by chemoradiotherapy in patients with stage IIIA-B non-small cell lung cancer (NSCLC)
31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Turkey, 29 September - 03 October 2006, vol.17, pp.229
Detection of circulating breast cancer cells in relation to therapy.
41st Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, United States Of America, 13 - 17 May 2005, vol.23
Immunoreactivity to SOX-1,-2,-3 and ZIC2 antigens and correlation to survival in small cell lung cancer (SCLC).
40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, United States Of America, 5 - 08 June 2004, vol.22
Oral etoposide in patients with small cell lung cancer
EUROPEAN JOURNAL OF CANCER, Oxford, United Kingdom, 01 September 1997, vol.33, no.8, pp.1072
Küçük hücreli dışı, akciğer kanserlerinde palyatif tedavide radyoterapi sonrası kemoterapinin yeri
I. Ulusal Radyasyon Onkolojisi Kongresi, İzmir, Turkey, 16 - 18 May 1994, pp.1563
Books & Book Chapters
Metrics
UN Sustainable Development Goals
